The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile
- 1 February 1999
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 40 (2), 167-170
- https://doi.org/10.1016/s0190-9622(99)70183-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Mucosal and Mucocutaneous (Generalized) Pemphigus Vulgaris Show Distinct Autoantibody ProfilesJournal of Investigative Dermatology, 1997
- Pemphigus Sera Recognize Conformationally Sensitive Epitopes in the Amino-Terminal Region of Desmoglein-1Journal of Investigative Dermatology, 1995
- Antigen-Specific Immunoadsorption of Pathogenic Autoantibodies in Pemphigus FoliaceusJournal of Investigative Dermatology, 1995
- Pemphigus Foliaceus and Pemphigus Vulgaris Autoantibodies React with the Extracellular Domain of Desmoglein-1Journal of Investigative Dermatology, 1995
- Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus.JCI Insight, 1994
- Identification of the Ubiquitous Human Desmoglein, Dsg2, and the Expression Catalogue of the Desmoglein Subfamily of Desmosomal CadherinsExperimental Cell Research, 1994
- Cell Adhesion Molecules as Targets of Autoantibodies in Pemphigus and Pemphigoid, Bullous Diseases Due to Defective Epidermal Cell AdhesionAdvances in Immunology, 1993
- Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesionCell, 1991
- Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen.JCI Insight, 1988
- Human autoantibodies against a desmosomal protein complex with a calcium-sensitive epitope are characteristic of pemphigus foliaceus patients.The Journal of Experimental Medicine, 1987